InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
80.46
(
-0.15%
)
Bitcoin
68,584.99
(
0.45%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: ampakine post# 1272

Tuesday, 08/10/2010 2:25:08 PM

Tuesday, August 10, 2010 2:25:08 PM

Post# of 80490

i'm betting on the best minds in the Sarcoma community



Great. Then you must have evidence of a quote from one of the "best minds" in the sarcoma community that says ridaforolimus is essentially a shoe-in at 95% success rate. I can tell you one thing - you're not even close. Not a SINGLE doctor would ever give such a ludicrous statement.

As far as the other monies from Merck, it's all speculation on your part. You have no idea if and when another Phase 3 trial will begin. Heck, they haven't even finished or given any data in P2 trials yet, and it doesn't look like its coming any time soon.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up